PuraPharm Corporation Limited (SEHK: 1498)
Health Care · Pharmaceuticals · HK
HK$0.28
-3.45% today · -39.8% 1Y
PuraPharm Corporation Limited (SEHK: 1498) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $19.11M and employs 441 people.
Over the last twelve months the share price has lost 39.8%, trading between 0.27 and 0.47.
Tweenvest scores PuraPharm Corporation Limited across four factors: quality 47/100, value 58/100, growth 0/100. Its strongest factor is value.
1498 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $19.11M
- Revenue (TTM)
- $43.18M
- P/E
- —
- EPS
- -0.08
- Dividend yield
- —
- Beta (5Y)
- 0.20
- 52-week high
- HK$0.47
- 52-week low
- HK$0.27
- Avg volume (3M)
- —
- Shares outstanding
- 535.05M
- Employees
- 441
- Next earnings
- —
About PuraPharm Corporation Limited
PuraPharm Corporation Limited, an investment holding entity, focuses on the research, development, manufacturing, and global distribution of concentrated Chinese medicine granules (CCMG) and various Chinese healthcare products across Hong Kong, Mainland China, and international markets. Its operations are structured into five key divisions: China CCMG, Hong Kong CCMG, Chinese Healthcare Products, Clinics, and Plantation. The company offers a range of over-the-counter health solutions under brand names such as PuraGold, Haveron, Oncozac, and Immuzac. Beyond product sales, PuraPharm provides a clinic management system for general Chinese medical practices and operates its own chain of Nong's Chinese medicine clinics, which deliver both traditional medical services and CCMG products. The company also oversees the cultivation and trade of raw Chinese herbs, in addition to manufacturing and selling traditional Chinese medicine decoction pieces. Complementing its product offerings, it delivers modernized Chinese medicine services and diagnostic consultations. PuraPharm distributes its goods to hospitals, healthcare institutions, medical professionals, and directly to consumers via an online store. The company currently manages 43 Nong's clinics in Hong Kong and one in Guangxi, China. Founded in 1998, its headquarters are located in Tai Po, Hong Kong.
- ISIN
- KYG7306Y1044
- Founded
- 1998
- Listed since
- Jul 8, 2015
- Exchange
- The Stock Exchange of Hong Kong Ltd.
- Currency
- HKD
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.10T | $1,233.66 | -1.06% |
| Johnson & JohnsonNYSE: JNJ | $658.24B | $273.14 | +0.04% |
| Merck & Co., Inc.NYSE: MRK | $385.99B | $156.45 | +3.84% |
| Roche Holding AGSWX: ROP | $371.62B | CHF373.80 | +0.92% |
| Novartis AGSWX: NOVN | $303.81B | CHF128.34 | +1.25% |
| AstraZeneca PLCLSE: AZN | $263.84B | £124.76 | +3.02% |
| Novo Nordisk A/SCPSE: NOVO B | $212.51B | Dkr307.80 | +2.86% |
| Pfizer Inc.NYSE: PFE | $162.84B | $28.57 | +2.15% |
Figures last refreshed Aug 18, 2026.